Man-Son-Hing M, Laupacis A, O'Connor A M, Hart R G, Feldman G, Blackshear J L, Anderson D C
Clinical Epidemiology Unit, Loeb Health Research Institute, Ottawa, Ontario, Canada.
J Gen Intern Med. 2000 Oct;15(10):723-30. doi: 10.1046/j.1525-1497.2000.90909.x.
With patients demanding a greater role in the clinical decision-making process, many researchers are developing and disseminating decision aids for various medical conditions. In this article, we outline the essential elements in the development and evaluation of a decision aid to help patients with atrial fibrillation choose, in consultation with their physicians, appropriate antithrombotic therapy (warfarin, aspirin, or no therapy) to prevent stroke. We also outline possible future directions regarding the implementation and evaluation of this decision aid. This information should enable clinicians to better understand the role that decision aids may have in their interactions with patients.
随着患者要求在临床决策过程中发挥更大作用,许多研究人员正在针对各种医疗状况开发并推广决策辅助工具。在本文中,我们概述了一种决策辅助工具的开发与评估中的关键要素,该工具旨在帮助房颤患者与医生协商后选择合适的抗血栓治疗方案(华法林、阿司匹林或不进行治疗)以预防中风。我们还概述了该决策辅助工具在实施与评估方面未来可能的发展方向。这些信息应能使临床医生更好地理解决策辅助工具在其与患者互动中可能发挥的作用。